Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Antiandrogen treatments can help with various women's health issues but often require ongoing use.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

PCOS may be influenced by factors in the blood, not just the ovaries.

Treatment during development affects hormone balance and sexual behavior in male rats.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Too much androgen can cause hair loss; finasteride may help.